Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Sonoma Pharmaceuticals Inc

SNOA
Current price
2.92 USD -0.03 USD (-1.02%)
Last closed 2.86 USD
ISIN US83558L2043
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 3 734 749 USD
Yield for 12 month -14.57 %
1Y
3Y
5Y
10Y
15Y
SNOA
21.11.2021 - 28.11.2021

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye and nasal care, oral care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. The company offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis; and Pediacyn, an atopic dermatitis hydrogel. It also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, the company offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, an antimicrobial prescription solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns for use in emergencies and on mucous membranes, cuts, abrasions, burns, and body surfaces; and Endocyn root canal irrigation solutions. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado. Address: 5445 Conestoga Court, Boulder, CO, United States, 80301

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

30 USD

P/E ratio

Dividend Yield

Current Year

+12 735 000 USD

Last Year

+13 272 000 USD

Current Quarter

+3 391 000 USD

Last Quarter

+3 439 000 USD

Current Year

+4 745 000 USD

Last Year

+4 477 000 USD

Current Quarter

+1 306 000 USD

Last Quarter

+1 091 000 USD

Key Figures SNOA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -4 464 000 USD
Operating Margin TTM -34.59 %
PE Ratio
Return On Assets TTM -19.59 %
PEG Ratio
Return On Equity TTM -74.65 %
Wall Street Target Price 30 USD
Revenue TTM 12 699 000 USD
Book Value 5.24 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -1.1 %
Dividend Yield
Gross Profit TTM 4 477 000 USD
Earnings per share -6.2 USD
Diluted Eps TTM -6.2 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -35.91 %

Dividend Analytics SNOA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History SNOA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 30.08.2024
Dividend Date 20.06.2019

Stock Valuation SNOA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.1233
Price Sales TTM 0.2941
Enterprise Value EBITDA -0.1682
Price Book MRQ 0.7507

Financials SNOA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SNOA

For 52 weeks

2.32 USD 9.37 USD
50 Day MA 3.24 USD
Shares Short Prior Month 106 518
200 Day MA 3.86 USD
Short Ratio 0.22
Shares Short 79 898
Short Percent 6.06 %